HOME
DV NEWS
SERVICE ARCHIVE SUBMISSIONS/CONTACT ABOUT DV
Viagra
for Girls
Medical
Light Bulbs Can't Switch off Relationship Woes
by
Barbara Sumner Burstyn
I
have a confession. When Viagra first came out, I gave it a go. Purely in the
interests of research, you understand.
It
was an unnerving experience. The blood accelerating through my veins to a
single destination. Once there, it was as though I had a massive migraine down
below. There was a distressing intensity that gave me a new respect for the
forces that men must grapple with regularly.
It
was like being inside that old anti-male joke: if I could have a penis for a
day, I'd stay home and wait for it to go away. But seriously, if that was male
sexual desire then no wonder men are from Mars.
But,
of course, it's not. While Viagra's success may have been based on a simplified
answer to impotence: the if-you-build-it-they'll-come theory, sexual
relationships turn out to be more complex.
Dr
Abraham Morgentaler, a urologist at Harvard Medical School, says in his book
The Viagra Myth that the drug has left a trail of broken relationships and
shattered expectations. He estimates that sales of Viagra are down by 50 per
cent and says many of his patients have come to realise that achieving a great
erection does not solve their relationship problems. In fact, it has often made
them worse.
Another
light-bulb moment in the history of medical science. Sadly it isn't
illuminating enough to halt the race to replace the lost sales of Viagra.
Now
female sexuality is about to receive a makeover. Ten pharmaceutical companies
are thought to be racing to create a feminine Viagra bonanza. But, for now, the
way is being paved by herbal supplements. First out of the gates is Avlimil.
US
print and television advertisements claim that 50 million women suffer from
sexual dysfunction. "Reclaim Your Sensuality", their ads shriek.
"They have Viagra. Now we have Avlimil."
While
men were duped (although realistically, they didn't take a lot of convincing)
into believing that erectile function was the basis of relationship success,
the new products are attempting to be a little more sophisticated. They claim
to address the whole issue of female sexual dysfunction.
Packaged
like contraceptives pills and, like the Pill, designed to be taken every day,
it's as though the implication of a daily dosage designed to keep you sexually
available has passed the makers by. As if they're intent on reinventing the
sexual dynamic in relationships, thereby reducing it to a series of treatable
external impediments to the holy grail of orgasm.
Avlimil's
website states that things such as stress, depression, childbirth, medications
and hormonal fluctuations all effect sexual arousal. Reading their blurb is
like listening to your former husband's point of view. It makes sense only if
you close one eye and half your mind in an attempt to understand the left-brain
logic of it.
None
of these things creates sexual dysfunction. Instead, a reduction in sexual
desire following childbirth, a bout of depression or the hormonal fluctuations
of maturing are not symptoms - they're signposts, flashing neon's to the
complexity of each of us.
We
are not purely sexual and we do not exist to satisfy sexual desire, ours or
theirs.
And
that's the crux of this issue. As the advertising inevitably increases, so will
the expectations of our sexual response. As we compare ourselves against a
pharmaceutically defined norm, so will men.
In
many ways this move towards creating the entirely sexually available woman is
the logical step that began with the contraceptive pill.
Aside
from the huge gains women experienced by being able to control conception,
there was, and is, a downside to the Pill that is rarely talked about: the
subtle attitude change that men had to women when their sexual availability
opened up. This new pill will take that underlying attitude and ratchet it up
more than a few notches.
Controlled
by medication, desire becomes a commodity, something you buy, not something you
own. By entering the realm of women's sexual response and defining it by
diagnosis and dosage, the chemists are plunging into privacy and changing what
it means to think and feel, the very position of sex in a relationship altered
by advertising.
This
is not medical science; it's a cruel vaudeville, a bastardization of the
promise of medicine to resolve the world's ills.
In
reality, 20 per cent of women are thought to suffer from medically treatable
sexual dysfunction. The rest of us, the ones the marketing is aimed at, are no
more dysfunctional than my neutered cat. Sexual desire ebbs and flows,
sometimes it's seasonal, sometimes lack of desire is the mind's way of inducing
rest from the melee.
And
sometimes it's simply an inner voice telling you that enough is enough.
While
the makers of Viagra say their female sexual dysfunction drug is still a couple
of years away, let's hope for a new kind of sexual revolution. One where we see
ourselves holistically, as sensual not sexual, as creatures capable of rare
intimacy, the type of closeness that overrides the shallow pharmaceutical
definition of desire.
Barbara Sumner
Burstyn is a freelance writer who commutes between Montreal, Quebec and
The Hawkes Bay in New Zealand. She writes a weekly column for the New Zealand
Herald (www.nzherald.co.nz), and has
contributed to a wide range of media. She can be reached at: barb@sumnerburstyn.com. Visit her
website to read more of her work: http://www.sumnerburstyn.com/.
* No Room
on the Balance Sheet for Truth or Humanity
* Working
to Live has Been Overtaken by Living to Work